Brief: Atossa Therapeutics And Quantum Leap Healthcare Announce New Study Arm To Evaluate (Z)-Endoxifen In The Ongoing I-Spy 2 Clinical Trial
21/03/2023 13:16
March 21 (Reuters) - Atossa Therapeutics Inc ATOS.O :
* ATOSSA THERAPEUTICS AND QUANTUM LEAP HEALTHCARE ANNOUNCE
NEW
STUDY ARM TO EVALUATE (Z)-ENDOXIFEN IN THE ONGOING I-SPY 2
CLINICAL TRIAL
* ATOSSA THERAPEUTICS - WILL SUPPLY (Z)-ENDOXIFEN AND
PROVIDE
FINANCIAL SUPPORT TO QUANTUM LEAP FOR STUDY
* ATOSSA THERAPEUTICS - QUANTUM LEAP, AS SPONSOR, WILL
PROVIDE
CLINICAL SITES AND CLINICAL EXPERTISE
Source text for Eikon: ID:nGNX9PZnY2
Further company coverage: ATOS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary